1 |
Peters, G. J., van Groeningen, C. J., Laurensse, E., Kraal, I., Leyva A., Lankelma, J. and Pinedo, H. M. (1987) Effect of pyrimidine nucleosides on body temperatures of man and rabbit in relation to pharmacokinetic data. Pharm. Res. 4, 113-119.
DOI
|
2 |
Al Safarjalani, O. N., Zhou, X. J., Naguib, F. N., Shi, J., Schinazi, R. F. and el Kouni, M. H. (2001) Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy. Cancer Chemother. Pharmacol. 48, 389-397.
DOI
ScienceOn
|
3 |
Chang, K. C., Oh, J. Y., In, Y. S., Kim, M. K., Shin, K.C., Wee, W. R., Lee, J. H. and Park, M. (2009) Preliminary effects of oral uridine on the ocular surface in dry eye patients. J. Kor. Med. Sci. 24, 701-707.
DOI
ScienceOn
|
4 |
Kang, W. Quantitative determination of uridine in rabbit plasma and urine by liquid chromatography coupled to a tandem mass spectrometry. (2012) Biomed. Chromatogr. 26, 541-544.
DOI
ScienceOn
|
5 |
Klubes, P., Geffen, D. B. and Cysyk, R. L. (1986) Comparison of the bioavailability of uridine in mice after either oral or parenteral administration. Cancer Chemother. Pharmacol. 17, 236-240.
|
6 |
Oh, J. Y, In, Y. S., Kim, M. K., Ko, J. H., Lee, H. J., Chin, K. C., Lee, S. M., Wee, W. R., Lee, J. H. and Park, M. (2007) Protective effect of uridine on cornea in a rabbit dry eye model. Invest. Ophthalmol. Vis. Sci., 48, 1102-1109.
DOI
ScienceOn
|